SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-17-000165
Filing Date
2017-02-24
Accepted
2017-02-24 14:54:39
Documents
1
Group Members
ALAN FRAZIERFHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.FHM VI, LLCFHM VI, LPFRAZIER LIFE SCIENCES VIII, L.P.JAMES TOPPERNADER NAININATHAN EVERYPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 FRAZIER HEALTHCARE VI, L.P. / SIERRA ONCOLOGY, INC. -- SCHEDULE 13D frazier-sierra13d_18034.htm SC 13D 340703
  Complete submission text file 0001072613-17-000165.txt   342553
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89009 | Film No.: 17636624
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 206-621-7200
Frazier Healthcare VI, L.P. (Filed by) CIK: 0001456656 (see all company filings)

IRS No.: 000000000
Type: SC 13D